These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 10825308)

  • 1. The effect of epsilon-aminocaproic acid on HemoSTATUS and kaolin-activated clotting time measurements.
    Saleem R; Bigham M; Spitznagel E; Despotis GJ
    Anesth Analg; 2000 Jun; 90(6):1281-5. PubMed ID: 10825308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of MDCO-2010, a serine protease inhibitor, on activated clotting time in blood obtained from volunteers and cardiac surgical patients.
    Kim H; Szlam F; Tanaka KA; van de Locht A; Ogawa S; Levy JH
    Anesth Analg; 2012 Aug; 115(2):244-52. PubMed ID: 22584552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of prophylactic epsilon-aminocaproic acid on bleeding, transfusions, platelet function, and fibrinolysis during coronary artery bypass grafting.
    Troianos CA; Sypula RW; Lucas DM; D'Amico F; Mathie TB; Desai M; Pasqual RT; Pellegrini RV; Newfeld ML
    Anesthesiology; 1999 Aug; 91(2):430-5. PubMed ID: 10443606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antithrombin III during cardiac surgery: effect on response of activated clotting time to heparin and relationship to markers of hemostatic activation.
    Despotis GJ; Levine V; Joist JH; Joiner-Maier D; Spitznagel E
    Anesth Analg; 1997 Sep; 85(3):498-506. PubMed ID: 9296400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients.
    Despotis GJ; Levine V; Filos KS; Santoro SA; Joist JH; Spitznagel E; Goodnough LT
    Anesthesiology; 1996 Dec; 85(6):1311-23. PubMed ID: 8968178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of activated coagulation time and whole blood heparin measurements with laboratory plasma anti-Xa heparin concentration in patients having cardiac operations.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Spitznagel E; Cox JL; Lappas DG
    J Thorac Cardiovasc Surg; 1994 Dec; 108(6):1076-82. PubMed ID: 7983877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative antifibrinolysis and blood-saving techniques in cardiac surgery. Prospective trial of 3 antifibrinolytic drugs.
    Penta de Peppo A; Pierri MD; Scafuri A; De Paulis R; Colantuono G; Caprara E; Tomai F; Chiariello L
    Tex Heart Inst J; 1995; 22(3):231-6. PubMed ID: 7580360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of epsilon-aminocaproic acid on fibrinolysis and thrombin generation during cardiac surgery.
    Slaughter TF; Faghih F; Greenberg CS; Leslie JB; Sladen RN
    Anesth Analg; 1997 Dec; 85(6):1221-6. PubMed ID: 9390584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epsilon aminocaproic acid reduces blood transfusion and improves the coagulation test after pediatric open-heart surgery: a meta-analysis of 5 clinical trials.
    Lu J; Meng H; Meng Z; Sun Y; Pribis JP; Zhu C; Li Q
    Int J Clin Exp Pathol; 2015; 8(7):7978-87. PubMed ID: 26339364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relationship between hirudin and activated clotting time: implications for patients with heparin-induced thrombocytopenia undergoing cardiac surgery.
    Despotis GJ; Hogue CW; Saleem R; Bigham M; Skubas N; Apostolidou I; Qayum A; Joist JH
    Anesth Analg; 2001 Jul; 93(1):28-32. PubMed ID: 11429333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sonorheometry assessment of platelet function in cardiopulmonary bypass patients: Correlation of blood clot stiffness with platelet integrin αIIbβ3 activity, aspirin usage, and transfusion risk.
    Viola F; Lin-Schmidt X; Bhamidipati C; Haverstick DM; Walker WF; Ailawadi G; Lawrence MB
    Thromb Res; 2016 Feb; 138():96-102. PubMed ID: 26688324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-benefit and efficacy of aprotinin compared with epsilon-aminocaproic acid in patients having repeated cardiac operations: a randomized, blinded clinical trial.
    Bennett-Guerrero E; Sorohan JG; Gurevich ML; Kazanjian PE; Levy RR; Barberá AV; White WD; Slaughter TF; Sladen RN; Smith PK; Newman MF
    Anesthesiology; 1997 Dec; 87(6):1373-80. PubMed ID: 9416723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlations between activated clotting time values and heparin concentration measurements in young infants undergoing cardiopulmonary bypass.
    Guzzetta NA; Monitz HG; Fernandez JD; Fazlollah TM; Knezevic A; Miller BE
    Anesth Analg; 2010 Jul; 111(1):173-9. PubMed ID: 20519414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aprotinin prolongs activated and nonactivated whole blood clotting time and potentiates the effect of heparin in vitro.
    Despotis GJ; Filos KS; Levine V; Alsoufiev A; Spitznagel E
    Anesth Analg; 1996 Jun; 82(6):1126-31. PubMed ID: 8638779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of epsilon-aminocaproylamino acids on fibrin formation.
    Bruzgo I; Midura-Nowaczek K; Bruzgo M; Kaczyńska J; Roszkowska-Jakimiec W
    Acta Pol Pharm; 2006; 63(2):149-52. PubMed ID: 17514879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation.
    Dalmau A; Sabaté A; Acosta F; Garcia-Huete L; Koo M; Sansano T; Rafecas A; Figueras J; Jaurrieta E; Parrilla P
    Anesth Analg; 2000 Jul; 91(1):29-34. PubMed ID: 10866882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of antifibrinolytic agents on the life span of fibrin sealant.
    Pipan CM; Glasheen WP; Matthew TL; Gonias SL; Hwang LJ; Jane JA; Spotnitz WD
    J Surg Res; 1992 Oct; 53(4):402-7. PubMed ID: 1383616
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of heparin, haemodilution and aprotinin on kaolin-based activated clotting time: in vitro comparison of two different point of care devices.
    Dalbert S; Ganter MT; Furrer L; Klaghofer R; Zollinger A; Hofer CK
    Acta Anaesthesiol Scand; 2006 Apr; 50(4):461-8. PubMed ID: 16548858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of ε-Aminocaproic Acid in Neonates Undergoing Cardiac Surgery with Cardiopulmonary Bypass.
    Eaton MP; Alfieris GM; Sweeney DM; Angona RE; Cholette JM; Venuto C; Anderson B
    Anesthesiology; 2015 May; 122(5):1002-9. PubMed ID: 25723765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.